IRIS
CASTAGNA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.173
NA - Nord America 2.115
AS - Asia 909
AF - Africa 18
OC - Oceania 13
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 5.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.091
SE - Svezia 1.377
CN - Cina 688
IT - Italia 444
FI - Finlandia 139
SG - Singapore 126
DE - Germania 54
IE - Irlanda 53
IN - India 42
RU - Federazione Russa 25
GB - Regno Unito 19
FR - Francia 17
IR - Iran 15
CA - Canada 13
AU - Australia 12
EU - Europa 11
MX - Messico 10
BR - Brasile 9
NL - Olanda 9
HK - Hong Kong 7
JP - Giappone 7
PH - Filippine 7
PK - Pakistan 6
ES - Italia 5
EG - Egitto 4
NO - Norvegia 4
UA - Ucraina 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
HR - Croazia 3
ID - Indonesia 3
MD - Moldavia 3
RO - Romania 3
TR - Turchia 3
ZA - Sudafrica 3
AR - Argentina 2
MW - Malawi 2
NG - Nigeria 2
TH - Thailandia 2
TN - Tunisia 2
AT - Austria 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 5.251
Salva come PNG Salva come JPEG
Città #
Lawrence 542
Princeton 542
Shenzhen 410
New York 206
Milan 188
Ashburn 185
Shanghai 175
Helsinki 127
Boardman 102
Singapore 62
Dublin 50
Rome 38
Washington 32
Pune 30
Seattle 25
Los Angeles 13
Lappeenranta 12
Genoa 11
Borås 10
Hanover 8
Bologna 6
Busto Arsizio 6
Florence 6
Lahore 6
Melbourne 6
Padova 6
Paris 6
Santa Clara 6
Turin 6
Campodolcino 5
Iztapalapa 5
Maringá 5
Mexico City 5
Moscow 5
Vittoria 5
Beijing 4
Fremont 4
Hyderabad 4
Liverpool 4
Madrid 4
Perm 4
Quezon City 4
Sydney 4
Trondheim 4
West Jordan 4
Angera 3
Ballincollig 3
Brescia 3
Cesano Boscone 3
Chisinau 3
Durban 3
Gatchina 3
Guardiagrele 3
Lviv 3
Messina 3
Ostuni 3
Pioltello 3
Rockville 3
Segrate 3
St Petersburg 3
Vancouver 3
Zagreb 3
Al Mansurah 2
Amsterdam 2
Andover 2
Anzio 2
Athens 2
Berlin 2
Bibiana 2
Blantyre 2
Boston 2
Brisbane 2
Bucharest 2
Casorezzo 2
Castellanza 2
Chengdu 2
Duchcov 2
Filottrano 2
Ghent 2
Gosport 2
Haywards Heath 2
Hong Kong 2
Jakarta 2
Katsina 2
Modena 2
Montreal 2
Monza 2
Novara 2
Nuremberg 2
Palmas 2
Panchkula 2
Paola 2
Paullo 2
Petriolo 2
Pisa 2
Ponsacco 2
Redwood City 2
Saint-Fons 2
Secaucus 2
Sestri Levante 2
Totale 3.019
Salva come PNG Salva come JPEG
Nome #
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 418
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 57
Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study) 50
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 44
null 39
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 37
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 37
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 34
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 32
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 32
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 31
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 29
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 27
Biobanking for COVID-19 research 26
Viral bloodstream detection in mpox patients: An observational multicentric study 25
Response to combination antiretroviral therapy: Variation by age 25
Subclinical myocardial dysfunction in patients recovered from COVID-19 25
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 24
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 24
Testosterone in males with COVID-19: A twelve-month cohort study 23
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 23
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 23
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 23
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 23
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 23
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 22
Severely low testosterone in males with COVID-19: a case-control study 22
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 21
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 21
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 21
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 21
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 20
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 20
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 20
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 20
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome 20
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 19
A follow-up study in asymptomatic HIV patients 19
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 19
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 19
VIRO-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression 19
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 19
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 18
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 18
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 18
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 18
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 18
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 18
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 18
Rugarli. Medicina interna sistematica 18
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 18
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 18
Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy 17
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 17
Switching antiretrovirals in older patients 17
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 17
Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection 17
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 16
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 16
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients 16
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study 16
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 16
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 16
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 16
Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection 16
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series 16
null 15
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 15
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 15
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial 15
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 15
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 15
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 15
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study 15
Erratum: Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV (BMC infectious diseases (2021) 21 1 (557)) 15
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 15
Beyond stigma: Monkeypox infection in a 27-year-old woman 14
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 14
In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: Preliminary results 14
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 14
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination 14
CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 14
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 14
An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study 14
Mortality in migrants living with HIV in western Europe (1997-2013): A collaborative cohort study 14
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 14
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 14
Rhodococcus defluvii pneumonia: First reported case in humans 14
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 14
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 14
Impact of multi-drug resistance on mortality: a multi-cohort Italian study 14
Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV 14
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 14
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 14
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 13
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients 13
Proctitis and prostatitis by Neisseria meningitidis among MSM: A case series 13
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 13
Totale 2.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 71 0 0 0 0 0 0 0 0 0 1 1
2020/2021235 2 0 1 23 0 51 11 131 5 0 7 4
2021/2022417 1 0 0 137 26 29 36 64 36 29 16 43
2022/20232.833 1.206 552 220 27 36 257 174 185 98 19 35 24
2023/20242.171 45 66 641 171 178 408 59 180 8 45 122 248
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 6.111